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INTRODUCTION: Intervertebral disc (IVD) degeneration is associated with low back pain. 
However, the molecular changes during the degeneration process is not entirely clear. The loss of 
nucleus pulposus (NP) integrity is one of the early events of the degeneration. Chondrogenic 
markers, such as SOX9 and aggrecan, have been commonly used to assess the degree of IVD 
degeneration. Recent transcriptomic studies have proposed several other candidates that may 
mark IVD degeneration. These include cartilage oligomeric matrix protein (COMP), matrix gla 
protein (MGP)[1], fibulin 1 (FBLN1) [2], cytokeratin 18 (KRT18) [3], cadherin-2 (CDH2) [3], 
cytokeratin 19 (KRT19) [2], and Runt-related transcription factor 2 (RUNX2) [4]. Studies also 
demonstrated that degenerated NP attains a fibrocartilaginous phenotype [5,6] with increased 
collagen stiffness and diameter, which can be rescued by the transplantation of mesenchymal 
stem cells [7], suggesting fibrotic events may play a role in IVD degeneration. This study aims to 
explore whether profibrotic and fibrosis markers, including COL1A1, COL3A1, FN1, HSP47, 
and MMP12, may serve as indicators of IVD degeneration in human through a comparative 
analysis with the conventional and recently proposed IVD degeneration markers. The association 
between IVD degeneration and activities of myofibroblasts, an important mediator of tissue 
fibrosis, was also investigated. 
 
METHODS: Human IVD were collected from eleven patients with disc degeneration (graded IV-
V at the Schneiderman scale) undergoing discectomy, and from eight patients undergoing 
corrective scoliosis surgery (as non-
Hospital in Hong Kong with informed patient consent and corresponding approval from 
institutional review board (IRB). RNA was isolated from human NP cells derived from 
degenerated discs graded IV-V at the Schneiderman scale (n=4) and non-degenerated (scoliosis) 
discs (n=3). Quantitative real-time PCR was performed on a Stepone Plus system (Applied 
Biosystems, USA) to determine the expression of three gene categories. The first group of 
traditional chondrogenic genes included ACAN and SOX9. The second group of potential NP 
degeneration indicators included CDH2, KRT19, KRT18, FBLN1, MGP and COMP. The third 
group of fibrosis related genes included COL1A1, COL3A1, FN1, HSP47, and MMP12. GAPDH 
was used as the endogenous control, and the relative quantification was achieved by comparative 
CT (cycle threshold) method. The co-expression of MMP12 and myofibroblast-related markers, 
including fibroblast specific protein 1 (FSP1) and ?-smooth muscle actin (?-SMA), were 
investigated by immunostaining in non-degenerated and degenerated human IVD, and in rodent 
IVD undergoing natural ageing (6m to 24m) or degeneration, induced by 25G needle puncture 
through annulus fibrosus (AF), from pre-injury to 8 weeks post injury. MMP12 positivity was 
determined as the number of MMP12 positive cells divided by the total number of cells per whole 
section. 
 
RESULTS: KRT19 and MMP12 showed the most significant association with NP degeneration, 
where MMP12 was upregulated 6.7 fold (670%), and KRT19 was decreased -500 fold (0.002%) 
in degenerated NP cells compared to non-degenerated NP cells. The expression levels of 
COL1A1, FBLN1 and MGP were upregulated, while ACAN, SOX9 and KRT18 were 
downregulated, in the degenerated NP cells compared to non-degenerated NP cells but the 
differences were not statistically significant. The expression level of CDH2 was found to be 
similar between the degenerated and non-degenerated samples. 
Immunohistochemical analysis confirmed that both degenerated and non-degenerated human IVD 
have MMP12 positive cells (Figure 1A). Most of the MMP12 signal was intracellular, but was 
also occasionally detected in the territorial matrix. The percentage of MMP12 positive cells in 
degenerated human IVD was 3.7 fold of that in non-degenerated human IVD. Puncture-induced 
rat disc injury elevated the number of MMP12(+) cells in the peripheral NP and in the AF (Figure 
1B). Aged mice also showed higher MMP12 positivity in the NP compared to young mice 
(Figure 1C). In addition, the positivity of ?-SMA, a marker of myofibroblast, was also increased 
in degenerated human IVD compared to non-degenerated human IVD (Figure 2A). Double 
immunofluorescence revealed that the MMP12 positive cells were co-expressed with ?-SMA and 
FSP1 (Figure 2B), indicating that the increased MMP12 positivity in the degenerated IVD could 
be related to the infiltration or activation of myofibroblasts. 
 
DISCUSSION: Our study in human and animal models suggest that a loss of KRT19 expression 
and an increase of cellular MMP12 expression in the NP is characteristic of disc degenerative 
changes. MMP12 positivity in disc cells correlates with enhanced expression of the markers 
known to be expressed by myofibroblasts, including ?-SMA and FSP1, supporting that 
infiltration/ activation of myofibroblasts and fibrotic events are involved in IVD degeneration. 
MMP12 is found to be upregulated in many types of diseases, such as rheumatoid arthritis and 
chronic obstructive pulmonary disease. The over-expression or depletion of MMP12 has been 
shown to regulate the expression of other MMPs. Interestingly, MMP12 is recently found to be a 
transcription factor involved in cell immunity against viral infection. Our findings therefore imply 
an unidentified impact of MMP12 on disc cell homeostasis, which awaits further investigation. 
 
SIGNIFICANCE: This study identifies the profibrotic mediator MMP12 as a novel IVD 
degeneration indicator, and implies that pathogenesis of IVD degeneration involves an enhanced 
activity of myofibroblasts. Our findings signify a relationship between IVD degeneration and 
fibrotic events in NP. 
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